Top Markets
#1 Helium Helium +116.88%
#2 MowCat MowCat +87.68%
#3 Seeker Seeker +57.76%
#4 UnifAI Network UnifAI Network +33.98%
#5 TENDIES TENDIES +28.85%
#6 pipedog pipedog +22.05%
#7 Zylo Ecosystem Zylo Ecosystem +21.82%
#8 Tensor Tensor +19.08%
#9 Pons Pons +17.58%
#10 MarsCoin MarsCoin +16.53%
Coin of the day
Helium Helium
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Gyre Therapeutics, Inc. Gyre Therapeutics, Inc.

Gyre Therapeutics, Inc.

GYRE
Classifica tra le azioni #11143
Gyre Therapeutics, Inc. is a pharmaceutical company dedicated to discovering,... Gyre Therapeutics, Inc. is a pharmaceutical company dedicated to discovering, advancing, and bringing to market small-molecule drugs that target inflammation and fibrosis in various organs. The company's key anti-fibrotic medication, ETUARY (Pirfenidone), has received approval for treating idiopathic pulmonary fibrosis. Beyond this, ETUARY is also undergoing late-stage (Phase 3) clinical trials for several other conditions, including dermatomyositis and interstitial lung disease linked to systemic sclerosis, pneumoconiosis, and diabetic kidney disease. The company's pipeline further includes F351 (Hydronidone), a compound structurally related to ETUARY. F351 is currently in Phase 3 studies for chronic hepatitis B-induced liver fibrosis and is in Phase 1 trials for liver fibrosis associated with nonalcoholic associated steatohepatitis (NASH). Other programs in development feature F573, which is progressing through Phase 2 studies for acute and acute-on-chronic liver failure. Additionally, two early-stage candidates, F528 and F230, are in preclinical development, focusing on chronic obstructive pulmonary disease (COPD) and pulmonary arterial hypertension (PAH), respectively. Established in 2002, Gyre Therapeutics, Inc. is based in San Diego, California, and operates as a subsidiary of GNI USA, Inc.
Prezzo delle azioni
$6.61
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$736.94M
Variazione (1 giorno)
-1.05%
Variazione (1 anno)
-14.60%
Paese
US
Scambia Gyre Therapeutics, Inc. (GYRE)

Categoria

Healthcare
Il prezzo GYRE con la capitalizzazione del mercato della B
Gyre Therapeutics, Inc. Gyre Therapeutics, Inc.
GYRE
$6.61
Capitalizzazione di mercato di Gyre Therapeutics, Inc.(GYRE)
Capitalizzazione di mercato: $736.94M
A partire dal August 2026, Gyre Therapeutics, Inc. ha una capitalizzazione di mercato pari a $736.94M. Questo rende Gyre Therapeutics, Inc. la 11143rd azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Gyre Therapeutics, Inc. dal 2006 al 2026
GYRE in paragone con la classifica dei più popolari stocks
Il prezzo per GYRE Attivo B Capitalizzazione del mercato a B Risultati
Gyre Therapeutics, Inc. Gyre Therapeutics, Inc.
$47,214.30 $736.94M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.264T +714,185.88%
Gyre Therapeutics, Inc. Gyre Therapeutics, Inc.
$42,168.13 $736.94M
Apple Inc. Apple Inc.
AAPL
$4.701T +637,844.41%
Gyre Therapeutics, Inc. Gyre Therapeutics, Inc.
$37,467.22 $736.94M
Alphabet Inc. Alphabet Inc.
GOOG
$4.177T +566,726.38%
Gyre Therapeutics, Inc. Gyre Therapeutics, Inc.
$34,240.20 $736.94M
Microsoft Corporation Microsoft Corporation
MSFT
$3.817T +517,906.12%
Gyre Therapeutics, Inc. Gyre Therapeutics, Inc.
$25,709.63 $736.94M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.866T +388,850.49%